Comparisons of serum miRNA expression profiles in patients with diabetic retinopathy and type 2 diabetes mellitus

OBJECTIVES: The aim of this study was to compare the expression levels of serum miRNAs in diabetic retinopathy and type 2 diabetes mellitus. METHODS: Serum miRNA expression profiles from diabetic retinopathy cases (type 2 diabetes mellitus patients with diabetic retinopathy) and type 2 diabetes mel...

Full description

Bibliographic Details
Main Authors: Jianping Ma, Jufang Wang, Yanfen Liu, Changyi Wang, Donghui Duan, Nanjia Lu, Kaiyue Wang, Lu Zhang, Kaibo Gu, Sihan Chen, Tao Zhang, Dingyun You, Liyuan Han
Format: Article
Language:English
Published: Elsevier España
Series:Clinics
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322017000200111&lng=en&tlng=en
_version_ 1818245697835630592
author Jianping Ma
Jufang Wang
Yanfen Liu
Changyi Wang
Donghui Duan
Nanjia Lu
Kaiyue Wang
Lu Zhang
Kaibo Gu
Sihan Chen
Tao Zhang
Dingyun You
Liyuan Han
author_facet Jianping Ma
Jufang Wang
Yanfen Liu
Changyi Wang
Donghui Duan
Nanjia Lu
Kaiyue Wang
Lu Zhang
Kaibo Gu
Sihan Chen
Tao Zhang
Dingyun You
Liyuan Han
author_sort Jianping Ma
collection DOAJ
description OBJECTIVES: The aim of this study was to compare the expression levels of serum miRNAs in diabetic retinopathy and type 2 diabetes mellitus. METHODS: Serum miRNA expression profiles from diabetic retinopathy cases (type 2 diabetes mellitus patients with diabetic retinopathy) and type 2 diabetes mellitus controls (type 2 diabetes mellitus patients without diabetic retinopathy) were examined by miRNA-specific microarray analysis. Quantitative real-time polymerase chain reaction was used to validate the significantly differentially expressed serum miRNAs from the microarray analysis of 45 diabetic retinopathy cases and 45 age-, sex-, body mass index- and duration-of-diabetes-matched type 2 diabetes mellitus controls. The relative changes in serum miRNA expression levels were analyzed using the 2-ΔΔCt method. RESULTS: A total of 5 diabetic retinopathy cases and 5 type 2 diabetes mellitus controls were included in the miRNA-specific microarray analysis. The serum levels of miR-3939 and miR-1910-3p differed significantly between the two groups in the screening stage; however, quantitative real-time polymerase chain reaction did not reveal significant differences in miRNA expression for 45 diabetic retinopathy cases and their matched type 2 diabetes mellitus controls. CONCLUSION: Our findings indicate that miR-3939 and miR-1910-3p may not play important roles in the development of diabetic retinopathy; however, studies with a larger sample size are needed to confirm our findings.
first_indexed 2024-12-12T14:37:02Z
format Article
id doaj.art-58ac1f880557495eb9df255033f20f33
institution Directory Open Access Journal
issn 1807-5932
1980-5322
language English
last_indexed 2024-12-12T14:37:02Z
publisher Elsevier España
record_format Article
series Clinics
spelling doaj.art-58ac1f880557495eb9df255033f20f332022-12-22T00:21:21ZengElsevier EspañaClinics1807-59321980-532272211111510.6061/clinics/2017(02)08S1807-59322017000200111Comparisons of serum miRNA expression profiles in patients with diabetic retinopathy and type 2 diabetes mellitusJianping MaJufang WangYanfen LiuChangyi WangDonghui DuanNanjia LuKaiyue WangLu ZhangKaibo GuSihan ChenTao ZhangDingyun YouLiyuan HanOBJECTIVES: The aim of this study was to compare the expression levels of serum miRNAs in diabetic retinopathy and type 2 diabetes mellitus. METHODS: Serum miRNA expression profiles from diabetic retinopathy cases (type 2 diabetes mellitus patients with diabetic retinopathy) and type 2 diabetes mellitus controls (type 2 diabetes mellitus patients without diabetic retinopathy) were examined by miRNA-specific microarray analysis. Quantitative real-time polymerase chain reaction was used to validate the significantly differentially expressed serum miRNAs from the microarray analysis of 45 diabetic retinopathy cases and 45 age-, sex-, body mass index- and duration-of-diabetes-matched type 2 diabetes mellitus controls. The relative changes in serum miRNA expression levels were analyzed using the 2-ΔΔCt method. RESULTS: A total of 5 diabetic retinopathy cases and 5 type 2 diabetes mellitus controls were included in the miRNA-specific microarray analysis. The serum levels of miR-3939 and miR-1910-3p differed significantly between the two groups in the screening stage; however, quantitative real-time polymerase chain reaction did not reveal significant differences in miRNA expression for 45 diabetic retinopathy cases and their matched type 2 diabetes mellitus controls. CONCLUSION: Our findings indicate that miR-3939 and miR-1910-3p may not play important roles in the development of diabetic retinopathy; however, studies with a larger sample size are needed to confirm our findings.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322017000200111&lng=en&tlng=entype 2 diabetes mellitusdiabetic retinopathyserum mirnas
spellingShingle Jianping Ma
Jufang Wang
Yanfen Liu
Changyi Wang
Donghui Duan
Nanjia Lu
Kaiyue Wang
Lu Zhang
Kaibo Gu
Sihan Chen
Tao Zhang
Dingyun You
Liyuan Han
Comparisons of serum miRNA expression profiles in patients with diabetic retinopathy and type 2 diabetes mellitus
Clinics
type 2 diabetes mellitus
diabetic retinopathy
serum mirnas
title Comparisons of serum miRNA expression profiles in patients with diabetic retinopathy and type 2 diabetes mellitus
title_full Comparisons of serum miRNA expression profiles in patients with diabetic retinopathy and type 2 diabetes mellitus
title_fullStr Comparisons of serum miRNA expression profiles in patients with diabetic retinopathy and type 2 diabetes mellitus
title_full_unstemmed Comparisons of serum miRNA expression profiles in patients with diabetic retinopathy and type 2 diabetes mellitus
title_short Comparisons of serum miRNA expression profiles in patients with diabetic retinopathy and type 2 diabetes mellitus
title_sort comparisons of serum mirna expression profiles in patients with diabetic retinopathy and type 2 diabetes mellitus
topic type 2 diabetes mellitus
diabetic retinopathy
serum mirnas
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322017000200111&lng=en&tlng=en
work_keys_str_mv AT jianpingma comparisonsofserummirnaexpressionprofilesinpatientswithdiabeticretinopathyandtype2diabetesmellitus
AT jufangwang comparisonsofserummirnaexpressionprofilesinpatientswithdiabeticretinopathyandtype2diabetesmellitus
AT yanfenliu comparisonsofserummirnaexpressionprofilesinpatientswithdiabeticretinopathyandtype2diabetesmellitus
AT changyiwang comparisonsofserummirnaexpressionprofilesinpatientswithdiabeticretinopathyandtype2diabetesmellitus
AT donghuiduan comparisonsofserummirnaexpressionprofilesinpatientswithdiabeticretinopathyandtype2diabetesmellitus
AT nanjialu comparisonsofserummirnaexpressionprofilesinpatientswithdiabeticretinopathyandtype2diabetesmellitus
AT kaiyuewang comparisonsofserummirnaexpressionprofilesinpatientswithdiabeticretinopathyandtype2diabetesmellitus
AT luzhang comparisonsofserummirnaexpressionprofilesinpatientswithdiabeticretinopathyandtype2diabetesmellitus
AT kaibogu comparisonsofserummirnaexpressionprofilesinpatientswithdiabeticretinopathyandtype2diabetesmellitus
AT sihanchen comparisonsofserummirnaexpressionprofilesinpatientswithdiabeticretinopathyandtype2diabetesmellitus
AT taozhang comparisonsofserummirnaexpressionprofilesinpatientswithdiabeticretinopathyandtype2diabetesmellitus
AT dingyunyou comparisonsofserummirnaexpressionprofilesinpatientswithdiabeticretinopathyandtype2diabetesmellitus
AT liyuanhan comparisonsofserummirnaexpressionprofilesinpatientswithdiabeticretinopathyandtype2diabetesmellitus